200 related articles for article (PubMed ID: 335787)
1. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
Fruensgaard K; Korsgaard S; Jorgensen H; Jensen K
Acta Psychiatr Scand; 1977 Oct; 56(4):256-64. PubMed ID: 335787
[No Abstract] [Full Text] [Related]
2. A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia.
Paprocki J; Versiani M
Curr Ther Res Clin Exp; 1977 Jan; 21(1):80-100. PubMed ID: 12922
[No Abstract] [Full Text] [Related]
3. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
Tuason VB
J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
[TBL] [Abstract][Full Text] [Related]
4. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
Selman FB; McClure RF; Helwig H
Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
[No Abstract] [Full Text] [Related]
5. Treatment of acute psychotic patients with loxapine parenterally.
Fruensgaard K; Jensen K
Curr Ther Res Clin Exp; 1976 Feb; 19(2):164-9. PubMed ID: 813953
[No Abstract] [Full Text] [Related]
6. Rapid tranquilization: a comparison of thiothixene with loxapine.
Dubin WR; Weiss KJ
J Clin Psychiatry; 1986 Jun; 47(6):294-7. PubMed ID: 3711026
[TBL] [Abstract][Full Text] [Related]
7. Loxapine concentrate in acute schizophrenia.
O'Connell RA; Jeewa M; Allen K
Curr Ther Res Clin Exp; 1977 Jan; 21(1):101-7. PubMed ID: 401704
[No Abstract] [Full Text] [Related]
8. Loxapine versus perphenazine in psychotic patients. A double-blind, randomized, multicentre trial.
Fruensgaard K; Wollenberg J; Hansen KM; Fensbo C; Sihm F
Curr Med Res Opin; 1978; 5(8):601-7. PubMed ID: 361345
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
Allen MH; Feifel D; Lesem MD; Zimbroff DL; Ross R; Munzar P; Spyker DA; Cassella JV
J Clin Psychiatry; 2011 Oct; 72(10):1313-21. PubMed ID: 21294997
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
San L; Estrada G; Oudovenko N; Vieta E
BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
Andrezina R; Josiassen RC; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; Iwamoto T
Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of loxapine hydrochloride oral concentrate (loxitane C) in acute schizophrenia.
Wittkopp TA
J Clin Psychiatry; 1978 Feb; 39(2):154-7. PubMed ID: 344304
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene.
Vianna Filho U; Versiani Caldeira V; Romildo Bueno J
Curr Ther Res Clin Exp; 1975 Sep; 18(3):476-90. PubMed ID: 810308
[No Abstract] [Full Text] [Related]
14. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
[TBL] [Abstract][Full Text] [Related]
15. Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
Tuason VB; Escobar JI; Garvey M; Schiele B
J Clin Psychiatry; 1984 Apr; 45(4):158-63. PubMed ID: 6370967
[TBL] [Abstract][Full Text] [Related]
16. Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.
Petrie WM; Ban TA; Berney S; Fujimori M; Guy W; Ragheb M; Wilson WH; Schaffer JD
J Clin Psychopharmacol; 1982 Apr; 2(2):122-6. PubMed ID: 7042770
[No Abstract] [Full Text] [Related]
17. A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients.
Kiloh LG; Williams SE; Grant DA; Whetton PS
J Int Med Res; 1976; 4(6):441-8. PubMed ID: 800384
[TBL] [Abstract][Full Text] [Related]
18. A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients.
Pool D; Bloom W; Mielke DH; Roniger JJ; Gallant DM
Curr Ther Res Clin Exp; 1976 Jan; 19(1):99-104. PubMed ID: 812671
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
[TBL] [Abstract][Full Text] [Related]
20. A controlled double-blind comparison between loxapine and haloperidol in acute newly hospitalized schizophrenic patients.
Paprocki J; Barcala Peixoto MP; Andrade NM
Psychopharmacol Bull; 1976 Apr; 12(2):32-4. PubMed ID: 769026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
